Pipeline
Project | Target | Disease | 2023 | 2024 | 2025 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AT-01 | To be disclosed | Hematologic and solid tumor |
|
||||||||||||||
AT-03 | To be disclosed | solid tumor |
|
||||||||||||||
AT-04 | To be disclosed | solid tumor |
|
||||||||||||||
AT-05 | To be disclosed | solid tumor |
|
Project | Target | Disease | 2023 | 2024 | 2025 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AT-01 | To be disclosed | Hematologic and solid tumor |
|
||||||||||||||
AT-03 | To be disclosed | solid tumor |
|
||||||||||||||
AT-04 | To be disclosed | solid tumor |
|
||||||||||||||
AT-05 | To be disclosed | solid tumor |
|